Abstract
GRAPPA, the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis, formed to address issues relevant to patients with psoriasis and psoriatic arthritis (PsA), comprises an international membership of dermatologists, rheumatologists, scientists, and representatives of patient organizations and the pharmaceutical industry. In September 2007, the group held a standalone annual meeting in Boston, Massachusetts. Plenary and breakout session topics included screening and assessment tools; quality measures; translational research, including individual sessions on bio-markers, imaging, and genetics; drug use and safety; and clinical and genetic registries. Presentations and deliberations by breakout groups are summarized in a series of articles.
Key Indexing Terms:Footnotes
-
D.D. Gladman, MD, FRCPC, President, GRAPPA; Professor of Medicine, University of Toronto.